Hypercapnic respiratory failure in systemic sclerosis

Journal of Clinical Rheumatology

Volumn 9, Issue 1, 2003, Pages 43-46

  Pugazhenthi, Muthiah ^a   Cooper, Dianne ^a   Ratnakant, B Sanjay ^a   Postlethwaite, Arnold ^a   Carbone, Laura ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Hypercapnic respiratory failure; Systemic sclerosis

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CORTICOSTEROID THERAPY; DYSPNEA; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; HYPERCAPNIA; LUNG ASPIRATION; LUNG FUNCTION TEST; LUNG PRESSURE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOSITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; QUADRICEPS FEMORIS MUSCLE; RESPIRATORY FAILURE; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; TREATMENT FAILURE; WEIGHT REDUCTION;

EID: 0037328689     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RHU.0000049714.86978.77     Document Type: Article

References (19)

1. Arroliga AC, Podell DN, Matthay RA. Pulmonary manifestations of systemic sclerosis. J Thorac Imaging 1992;7:30-45.
2. Minai O, Dweik R, Arroliga AC. Manifestations of systemic sclerosis pulmonary disease. Clin Chest Med 1998;19:713-31.
3. Clements PJ, Lachenbruch PA, Seibold JR, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20: 1892-6.
4. Nageh TT, Dubois RM. Non-invasive ventilation in hypercapnic respiratory failure secondary to sclerodermic chest wall restriction. Respir Med 1998;92:1170-2.
5. Chausow AM, Kane T, Levinson D, et al. Reversible hypercapnic respiratory insufficiency in systemic sclerosis caused by respiratory muscle weakness. Am Rev Respir Dis 1984; 130:142-4.
6. Russell DC, Maloney A, Muir AL. Progressive generalised systemic sclerosis: respiratory failure from primary chest wall involvement. Thorax 1981;36:219-20.
7. Glauser FL, Fairman RP, Bechard D. The causes and evaluation of chronic hypercapnea. Chest 1987;91:755-9.
8. Godfrey S, Bluestone R, Higgs BE. Lung function and the response to exercise in systemic sclerosis. Thorax 1969;24:427-35.
9. McCarthy DS, Baragar FD, Dhingra S, et al. The lung in systemic sclerosis (scleroderma): a review and new information. Semin Arthritis Rheum 1998;17:271-83.
10. American Thoracic Society. Standardization of spirometry. Update. Am J Respir Crit Care Med 1994;152:1107-36.
11. Newsom-Davis J. The diaphragm and neuromuscular disease. Am Rev Respir Dis 1997; 119:115-7.
12. Clements PJ, Furst DE, Campion DS, et al. Muscle disease in progressive systemic sclerosis. Arthritis Rheum 1978;21:62-71.
13. Medsger TA, Rodnan GP, Moossy J, et al. Skeletal muscle involvement in progressive systemic sclerosis (systemic sclerosis). Arthritis Rheum 1967;11:554-68.
14. Moxham J. Respiratory muscle fatigue: mechanisms, evaluation and therapy. Br J Anaesth 1990;65:45-53.
15. Moloney E, Kiely JL, McDonnell T, et al. Nocturnal nasal intermittent positive pressure ventilation (NIPPV). Therapy for chronic respiratory failure: Long-term effects. Ir Med J 1999;92:401-3.
16. Lang BA, Laxer RM, Murphy G, et al. Intravenous gammaglobulin. Am J Med 1991;91:169-72.
17. Cherin P, Herson S, Wechsler B, et al. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. Am J Med 1991;91:162-8.
18. Esteve E, Cambie MP, Serpier H, et al. Paraneoplastic dermatomyositis: efficacy of intravenous gammaglobulin. Br J Dermatol 1994; 131:917-8.
19. Levy Y, Sherer Y, Langevitz P, et al. Skin score decrease in systemic sclerosis patients treated with intravenous immunoglobulin - a preliminary report. Clin Rheumatol 2000;19:207-11.